Common Contracts

EX-10.5(B) 5 aimt-ex105b_1498.htm EX-10.5(B) AIMMUNE THERAPEUTICS, INC. SECURITIES PURCHASE AGREEMENT

Securities Purchase Agreement • May 5th, 2020 • New York

• Contract Type
  Securities Purchase Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  New York

This Securities Purchase Agreement (“Agreement”) is made as of November 3, 2016 (the “Effective Date”), between Aimmune Therapeutics, Inc., a Delaware corporation (the “Company”), and Nestle Health Science US Holdings, Inc., a Delaware corporation (the “Purchaser”).

AIMMUNE THERAPEUTICS, INC. SECURITIES PURCHASE AGREEMENT

Securities Purchase Agreement • March 15th, 2017 • Aimmune Therapeutics, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Securities Purchase Agreement
• Filed
  March 15th, 2017
• Company
  Aimmune Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This Securities Purchase Agreement (“Agreement”) is made as of November 3, 2016 (the “Effective Date”), between Aimmune Therapeutics, Inc., a Delaware corporation (the “Company”), and Nestle Health Science US Holdings, Inc., a Delaware corporation (the “Purchaser”).